Loading…
Seaport Therapeutics, Inc. is projected to rise to $19.59 by 2027, a +9% move from its current price of $18.05.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $16.64 | $18.03 | $19.53 | -0.12% |
| May 30 | $16.08 | $18.01 | $20.17 | -0.24% |
| May 31 | $15.66 | $17.99 | $20.66 | -0.36% |
| Jun 1 | $15.31 | $17.96 | $21.08 | -0.48% |
| Jun 2 | $15.00 | $17.94 | $21.46 | -0.59% |
| Jun 3 | $14.73 | $17.92 | $21.80 | -0.71% |
| Jun 4 | $14.48 | $17.90 | $22.12 | -0.83% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.48 | $17.90 | $22.12 | -0.83% |
| Week 2 | $13.16 | $17.75 | $23.95 | -1.66% |
| Week 3 | $12.20 | $17.60 | $25.41 | -2.47% |
| Week 4 | $11.43 | $17.46 | $26.67 | -3.29% |
| Week 5 | $10.78 | $17.31 | $27.80 | -4.09% |
| Week 6 | $10.22 | $17.17 | $28.85 | -4.89% |
| Week 7 | $9.72 | $17.03 | $29.82 | -5.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company focuses on therapeutic candidates for depression and anxiety disorders using its Glyph technology platform.
The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines.
The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.
Seaport Therapeutics, Inc. (SPTX) currently trades at $17.50 per share and has a market cap of $927.99M, ranking 2592 by market capitalization.
The current price sits within a longer-term forecast that points to a bullish trajectory in later years, with rising average prices and substantial upside shown in the 2030-2050 horizon.
Forecasts show a rising path across the years, with 2028 as a notable inflection point and 2050 standing out with an average price of $76.20 and a maximum forecast of $175.27. The projected ROI climbs to 335.5% by 2050, underscoring meaningful upside potential alongside ongoing volatility.
In the nearer years, the forecast provides a range of $12.66 to $52.96 for 2030 and highlights higher-long-term targets, including an average price of $26.01 in 2030 and an average of $76.20 in 2050, indicating a long-term bullish outlook.
A major floor 15.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.5% below — buyers have tended to step in here.
The nearest ceiling, 9.9% above — a clean break opens room to run.
A major ceiling 9.9% above — clearing it would confirm fresh momentum.
Key SPTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.25 | $18.05 | $29.68 | 0% | Neutral | |
| $12.63 | $19.59 | $32.83 | +9% | Neutral | |
| $14.69 | $25.24 | $45.88 | +40% | Bullish | |
| $14.96 | $28.16 | $54.47 | +56% | Bullish | |
| $13.25 | $27.20 | $55.35 | +51% | Bullish | |
| $11.21 | $24.91 | $52.95 | +38% | Bullish | |
| $9.88 | $21.97 | $48.51 | +22% | Bullish | |
| $10.72 | $23.81 | $54.41 | +32% | Bullish | |
| $12.09 | $26.86 | $61.78 | +49% | Bullish | |
| $14.47 | $32.16 | $73.96 | +78% | Bullish | |
| $12.19 | $27.09 | $62.31 | +50% | Bullish | |
| $35.32 | $78.49 | $180.52 | +335% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $15.25 | $18.05 | $21.73 | +0.00% |
| June 2026 | $14.20 | $17.41 | $22.35 | -3.56% |
| July 2026 | $12.87 | $16.19 | $21.56 | -7.00% |
| August 2026 | $13.44 | $17.27 | $23.64 | +6.67% |
| September 2026 | $14.40 | $18.82 | $26.34 | +8.99% |
| October 2026 | $13.97 | $18.55 | $26.48 | -1.43% |
| November 2026 | $13.80 | $18.59 | $26.99 | +0.22% |
| December 2026 | $14.73 | $20.12 | $29.68 | +8.20% |
Click any year to see its month-by-month SPTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SPTX to range from $15.25 to $29.68 through 2026. The $18.05 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The SPTX price prediction for 2027 points to an average of $19.59 (low $12.63, high $32.83) — a potential gain of +9% on today's $18.05. A consolidation phase looks the most probable path here.
In 2028, SPTX is projected to trade between $14.69 and $45.88, averaging $25.24 — a potential gain of +40% from today's $18.05. That is up +29% on the projected 2027 average. Momentum favours further upside here.
Seaport Therapeutics, Inc.'s 2029 outlook centres on $28.16, within a $14.96 to $54.47 range. That is up +12% on the projected 2028 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, SPTX could reach as high as $55.35, with a base case around $27.20 and support toward $13.25 — roughly +51% from $18.05. Momentum favours further upside here.
Expect SPTX to range from $11.21 to $52.95 through 2031. The $24.91 average target implies a +38% move from current prices. That is -8% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The SPTX price prediction for 2032 points to an average of $21.97 (low $9.88, high $48.51) — a potential gain of +22% on today's $18.05. Momentum favours further upside here.
In 2033, SPTX is projected to trade between $10.72 and $54.41, averaging $23.81 — a potential gain of +32% from today's $18.05. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Seaport Therapeutics, Inc.'s 2034 outlook centres on $26.86, within a $12.09 to $61.78 range. That is up +13% on the projected 2033 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2035, SPTX could reach as high as $73.96, with a base case around $32.16 and support toward $14.47 — roughly +78% from $18.05. Buyers look set to stay in control over this stretch.
Expect SPTX to range from $12.19 to $62.31 through 2040. The $27.09 average target implies a +50% move from current prices. That is -16% versus the projected 2035 average. Momentum favours further upside here.
The SPTX price prediction for 2050 points to an average of $78.49 (low $35.32, high $180.52) — a potential gain of +335% on today's $18.05. Buyers look set to stay in control over this stretch.
Investing $1,000 in SPTX today (≈ 55.401662 SPTX) could be worth
$4,348.21
+$3,348.21 (+335%) by 2050 · US Dollar
Based on the average projected SPTX price of $78.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPTXwould be worth at today's price.
$1,000 invested in SPTX on May 1, 2026 (≈ 50.403225 SPTX) would be worth
$909.78
-$90.22 (-9.0%) today · 0.91× · US Dollar
Based on a SPTX entry price of $19.84 vs. today's $18.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.78 | $1,143.85 | +14.4% |
| All time ago | $19.84 | $909.78 | -9.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPTX forecast.
Our base-case forecast reaches $36.00 around 2050.
Implied market cap at $36.00: $1.91B
The multi-year forecast shows a shift from neutral in 2026–2027 to bullish sentiment from 2028 onward, with rising average prices and outsized upside by the end of the horizon.
Key long-term figures include 2030 with an average price of $26.01 and a ROI of 48.6%, 2040 with an average price of $26.40 and a ROI of 50.9%, and 2050 with an average price of $76.20 and a ROI of 335.5%. The 2030, 2040, and 2050 milestones illustrate a pronounced growth trajectory despite shorter-term variability.
Other notable mid-term points include 2028 with an average of $24.24 and a max of $44.10 (ROI 38.5%), 2029 with an average of $27.49 and a max of $53.21 (ROI 57.1%), and 2035 with an average of $30.90 and a max of $71.06 (ROI 76.6%). These figures reflect a systemic, long-run bullish tilt, tempered by the likelihood of volatility and uncertainty inherent in equity-like forecasts.
These projections are estimates and not guarantees. The outlook is framed by the Glyph platform and the neuropsychiatric focus of Seaport Therapeutics, but actual results will depend on clinical development progress, regulatory decisions, and market dynamics.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $26.01, with a minimum of $12.66 and a maximum of $52.96, and an implied ROI of 48.6%.
The outlook is mixed in the near term (2026–2027 neutral) but turns bullish from 2028 onward, with the 2030–2050 period showing rising averages and high upside, including a 2050 ROI of 335.5%.
Yes. The forecast shows a 2050 maximum of $175.27, which exceeds $100; earlier years show lower maximums but the long-term path includes substantial upside.
The current price is $17.50 and the market cap is $927.99M.
The 30-day range is from $10.09 to $30.37.
Seaport Therapeutics, Inc. Community Discussion
0Share your Seaport Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.